AT

Atsenatx

3 known investors

atsenatx.com ↗

Atsena Therapeutics is a clinical-stage gene therapy company developing treatments for inherited retinal diseases. Its pipeline includes ATSN-201 for X-linked retinoschisis, ATSN-101 for LCA1, and earlier-stage programs for Usher Syndrome 1B and Stargardt disease.

Investors · 3

LI

Lightstone VenturesPortola Valley

HA

Hatteras Venture PartnersreportedResearch Triangle · $500K – $4M

SO

Sofinnova VenturesreportedMenlo Park · $100K – $15M